A 24-week randomized, multicenter, single blinded, international study to evaluate the effect of reminder notifications and motivational/adaptive messaging on treatment adherence of COPD subjects receiving Ultibro Breezhaler treatment using the Concept2 inhaler for dose tracking
Phase of Trial: Phase III
Latest Information Update: 28 Feb 2019
Price : $35 *
At a glance
- Drugs Glycopyrrolate/indacaterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Novartis Pharma A.G.
- 28 Feb 2019 This trial has been Suspended in Netherlands, according to European Clinical Trials Database.
- 14 Feb 2019 This trial has been Changed to Suspended to discontinued in Austria (End date: 2019-01-24) , according to European Clinical Trials Database.
- 28 Nov 2018 This trial has been Suspended in Austria, according to European Clinical Trials Database.